Xponance’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.7M | Buy |
257,608
+39,769
| +18% | +$4.27M | 0.23% | 69 |
|
|
2025
Q1 | $22M | Sell |
217,839
-1,300
| -0.6% | -$131K | 0.21% | 79 |
|
|
2024
Q4 | $19.6M | Buy |
219,139
+10,681
| +5% | +$954K | 0.18% | 87 |
|
|
2024
Q3 | $17.5M | Buy |
208,458
+4,247
| +2% | +$356K | 0.17% | 94 |
|
|
2024
Q2 | $15.7M | Sell |
204,211
-4,869
| -2% | -$375K | 0.16% | 102 |
|
|
2024
Q1 | $14.3M | Buy |
209,080
+17,082
| +9% | +$1.17M | 0.15% | 120 |
|
|
2023
Q4 | $11.1M | Buy |
191,998
+12,537
| +7% | +$725K | 0.13% | 130 |
|
|
2023
Q3 | $9.48M | Buy |
179,461
+8,181
| +5% | +$432K | 0.13% | 134 |
|
|
2023
Q2 | $9.26M | Sell |
171,280
-259
| -0.2% | -$14K | 0.12% | 136 |
|
|
2023
Q1 | $8.58M | Buy |
171,539
+3,669
| +2% | +$184K | 0.13% | 147 |
|
|
2022
Q4 | $7.77M | Buy |
167,870
+25,628
| +18% | +$1.19M | 0.13% | 156 |
|
|
2022
Q3 | $5.51M | Buy |
142,242
+22,725
| +19% | +$880K | 0.11% | 173 |
|
|
2022
Q2 | $4.45M | Buy |
119,517
+23,046
| +24% | +$859K | 0.09% | 188 |
|
|
2022
Q1 | $4.27M | Buy |
96,471
+4,259
| +5% | +$189K | 0.07% | 226 |
|
|
2021
Q4 | $3.92M | Buy |
92,212
+20,489
| +29% | +$870K | 0.06% | 245 |
|
|
2021
Q3 | $3.11M | Sell |
71,723
-6,619
| -8% | -$287K | 0.06% | 257 |
|
|
2021
Q2 | $3.35M | Buy |
78,342
+17,611
| +29% | +$753K | 0.06% | 252 |
|
|
2021
Q1 | $2.35M | Sell |
60,731
-1,224
| -2% | -$47.3K | 0.05% | 284 |
|
|
2020
Q4 | $2.23M | Buy |
61,955
+3,868
| +7% | +$139K | 0.05% | 295 |
|
|
2020
Q3 | $2.22M | Sell |
58,087
-192
| -0.3% | -$7.34K | 0.05% | 267 |
|
|
2020
Q2 | $2.05M | Buy |
+58,279
| New | +$2.05M | 0.05% | 268 |
|